首站-论文投稿智能助手
典型文献
Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease
文献摘要:
Aging is by far the most prominent risk factor for Alzheimer's disease(AD),and both aging and AD are associated with apparent metabolic alterations.As developing effective therapeutic interven-tions to treat AD is clearly in urgent need,the impact of modulating whole-body and intracellular meta-bolism in preclinical models and in human patients,on disease pathogenesis,have been explored.There is also an increasing awareness of differential risk and potential targeting strategies related to biological sex,microbiome,and circadian regulation.As a major part of intracellular metabolism,mitochondrial bioen-ergetics,mitochondrial quality-control mechanisms,and mitochondria-linked inflammatory responses have been considered for AD therapeutic interventions.This review summarizes and highlights these ef-forts.
文献关键词:
作者姓名:
Steven N.Austad;Scott Ballinger;Thomas W.Buford;Christy S.Carter;Daniel L.Smith Jr;Victor Darley-Usmar;Jianhua Zhang
作者机构:
Department of Biology,University of Alabama at Birmingham,Birmingham,AL 35294,USA;Department of Pathology,University of Alabama at Birmingham,Birmingham,AL 35294,USA;Department of Medicine,University of Alabama at Birmingham,Birmingham,AL 35294,USA;Department of Nutrition Sciences,University of Alabama at Birmingham,Birmingham,AL 35294,USA
引用格式:
[1]Steven N.Austad;Scott Ballinger;Thomas W.Buford;Christy S.Carter;Daniel L.Smith Jr;Victor Darley-Usmar;Jianhua Zhang-.Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease)[J].药学学报(英文版),2022(02):511-531
A类:
bioenergetics,bioen,ergetics,forts
B类:
Targeting,whole,body,metabolism,mitochondrial,drug,development,Alzheimer,disease,Aging,by,far,most,prominent,risk,AD,both,aging,associated,apparent,metabolic,alterations,developing,effective,therapeutic,treat,clearly,urgent,need,impact,modulating,intracellular,preclinical,models,human,patients,pathogenesis,have,been,explored,There,also,increasing,awareness,differential,potential,targeting,strategies,related,biological,sex,microbiome,circadian,regulation,major,part,quality,control,mechanisms,linked,inflammatory,responses,considered,interventions,This,review,summarizes,highlights,these
AB值:
0.584359
相似文献
Spirulina platensis aqueous extracts ameliorate colonic mucosal damage and modulate gut microbiota disorder in mice with ulcerative colitis by inhibiting inflammation and oxidative stress
Jian WANG;Liqian SU;Lun ZHANG;Jiali ZENG;Qingru CHEN;Rui DENG;Ziyan WANG;Weidong KUANG;Xiaobao JIN;Shuiqing GUI;Yinghua XU;Xuemei LU-Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances,School of Life Science and Biopharmaceutics,Guangdong Pharmaceutical University,Guangzhou 510006,China;School of Pharmacy,Guangdong Pharmaceutical University,Guangzhou 510006,China;Intensive Care Unit,Shenzhen Second People's Hospital,the First Affiliated Hospital of Shenzhen University,Shenzhen 518031,China;Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products,National Institutes for Food and Drug Control,Beijing 102629,China
Common mtDNA variations at C5178a and A249d/T6392C/G10310A decrease the risk of severe COVID?19 in a Han Chinese population from Central China
Yi Wu;Xian‑Hui Wang;Xi‑Hua Li;Li‑Yuan Song;Shi‑Long Yu;Zhi‑Cheng Fang;Yu‑Quan Liu;Le‑Yong Yuan;Chun‑Yan Peng;Shen‑Yi Zhang;Wang Cheng;Hong‑Chao Ma;Li‑Feng Wang;Jun‑Ming Tang;Yun‑Fu Wang;Fu‑Yun Ji-Department of Medical Biology,School of Basic Medical Science,Hubei University of Medicine,Shiyan 442000,Hubei,China;Institute of Biomedical Research,Hubei University of Medicine,Shiyan 442000,Hubei,China;Institute of Human Respiratory Disease,Xinqiao Hospital,The Army Medical University(Third Military Medical University),400037 Chongqing,China;Department of Emergency Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Geriatric Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Immunology,School of Basic Medical Sciences,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Laboratory Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Hubei Key Laboratory of Embryonic Stem Cell Research,School of Basic Medical Science,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Neurology,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China
Alzheimer's disease:current status and perspective
Wenying Liu;Serge Gauthier;Jianping Jia-Innovation Center for Neurological Disorders and Department of Neurology,Xuanwu Hospital,Capital Medical University,National Clinical Research Center for Geriatric Diseases,Beijing 100053,China;Departments of Neurology and Neurosurgery,and Department of Psychiatry,McGill Centre for Studies in Aging,McGill University,Montreal H4H1R3,Canada;Beijing Key Laboratory of Geriatric Cognitive Disorders,Beijing 100053,China;Clinical Center for Neurodegenerative Disease and Memory Impairment,Capital Medical University,Beijing 100053,China;Center of Alzheimer's Disease,Beijing Institute of Brain Disorders,Collaborative Innovation Center for Brain Disorders,Capital Medical University,Beijing 100053,China;Key Laboratory of Neurodegenerative Diseases,Ministry of Education,Beijing 100053,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。